Biotech News
ONGENO Secures €3.5 Million to Advance MS Stem Cell Trials
ONGENO, a Polish medtech startup, has secured €3.5 million in fresh funding to continue its medical trials aimed at treating multiple sclerosis (MS) with a novel stem cell therapy. The financing was provided through the issuance of 100 new shares,
23 January 2025